Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.48 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 12/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.38 |
| ▸ | BTK | Q06187 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680682 | 0.91 | KCNH2 (0.41) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL680634 | 0.87 | CACNA1F (0.67) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL679171 | 0.82 | ALDH1A1 (0.42) | POLBKCNH2MEN1KMT2ATOP2A | |
| SCHEMBL679172 | 0.81 | KCNH2 (0.51) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL680239 | 0.79 | KCNH2 (0.56) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL680312 | 0.76 | KDM4E (0.54) | POLBKCNH2MEN1KMT2AKDM4E | |
| SCHEMBL680113 | 0.73 | KDM4E (0.57) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL9522715 | 0.72 | CACNA1F (0.76) | CACNA1FPOLBMAPK1CACNA1DKCNH2 | |
| SCHEMBL680107 | 0.72 | KDM4E (0.46) | TOP2ATOP2BKDM4EALDH1A1HPGD | |
| SCHEMBL680228 | 0.71 | ALDH1A1 (0.57) | POLBKCNH2MEN1KMT2ATOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108557-A1 | FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS | ALCON RESEARCH, LTD. (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110160172-A1 | FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS | ALCON RESEARCH, LTD. (US) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160172-A1 | FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS | QARS1, UACA, CYP51A1 | CACNA1F 3937/4885POLB 276/4885MAPK1 1605/4885 |
| US-20120108557-A1 | FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS | QARS1, UACA, CYP51A1 | CACNA1F 3937/4885POLB 276/4885MAPK1 1605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.